These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9100066)

  • 1. Histology of leiomyomata in patients treated with leuprolide acetate.
    Demopoulos RI; Jones KY; Mittal KR; Vamvakas EC
    Int J Gynecol Pathol; 1997 Apr; 16(2):131-7. PubMed ID: 9100066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic changes in gonadotropin releasing hormone agonist analogue treated uterine leiomyomata.
    Deligdisch L; Hirschmann S; Altchek A
    Fertil Steril; 1997 May; 67(5):837-41. PubMed ID: 9130887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of leuprolide acetate treatment on histopathology of uterine myomata.
    Gutmann JN; Thornton KL; Diamond MP; Carcangiu ML
    Fertil Steril; 1994 Apr; 61(4):622-6. PubMed ID: 8150102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyalinization and cellular changes in uterine leiomyomata after gonadotropin releasing hormone agonist therapy.
    Cohen D; Mazur MT; Jozefczyk MA; Badawy SZ
    J Reprod Med; 1994 May; 39(5):377-80. PubMed ID: 7520497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological changes in leiomyomata treated with leuprolide acetate.
    Upadhyaya NB; Doody MC; Googe PB
    Fertil Steril; 1990 Nov; 54(5):811-4. PubMed ID: 2121550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic findings in 107 uterine leiomyomas treated with leuprolide acetate compared with 126 controls.
    Sreenan JJ; Prayson RA; Biscotti CV; Thornton MH; Easley KA; Hart WR
    Am J Surg Pathol; 1996 Apr; 20(4):427-32. PubMed ID: 8604809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of leuprolide acetate on treatment of leiomyomata--clues to mechanisms of action.
    Demopoulos RI; Mesia AF
    Adv Anat Pathol; 1998 Mar; 5(2):129-36. PubMed ID: 9868519
    [No Abstract]   [Full Text] [Related]  

  • 8. Aborted leiomyosarcoma after treatment with leuprolide acetate.
    Mesia AF; Williams FS; Yan Z; Mittal K
    Obstet Gynecol; 1998 Oct; 92(4 Pt 2):664-6. PubMed ID: 9764655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of gonadotropin-releasing hormone agonist treatment upon angiogenesis in uterine leiomyoma.
    Abulafia O; Kleinhaus K; Levi G; Lee YC; Sherer DM
    Gynecol Obstet Invest; 2001; 52(2):108-13. PubMed ID: 11586038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (leuprolide acetate).
    Mizutani T; Sugihara A; Nakamuro K; Terada N
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1253-5. PubMed ID: 9543151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine leiomyomata and sterility: therapy with gonadotropin-releasing hormone agonists and leiomyomectomy.
    Kuhlmann M; Gärtner A; Schindler EM; Regidor PA; Bühler K; Schindler AE
    Gynecol Endocrinol; 1997 Jun; 11(3):169-74. PubMed ID: 9209897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotropin-releasing hormone agonist use before hysterectomy.
    Stovall TG; Summit RL; Washburn SA; Ling FW
    Am J Obstet Gynecol; 1994 Jun; 170(6):1744-8; discussion 1748-51. PubMed ID: 8203435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent leuprolide acetate for the nonsurgical management of women with leiomyomata uteri.
    Scialli AR; Levi AJ
    Fertil Steril; 2000 Sep; 74(3):540-6. PubMed ID: 10973652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leuprolide acetate treatment and myoma arterial size.
    Rutgers JL; Spong CY; Sinow R; Heiner J
    Obstet Gynecol; 1995 Sep; 86(3):386-8. PubMed ID: 7651647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gonadotropin-releasing hormone agonists on uterine leiomyomas.
    Cramer SF
    Arch Pathol Lab Med; 1998 Dec; 122(12):1045-6. PubMed ID: 9870847
    [No Abstract]   [Full Text] [Related]  

  • 16. Estriol add-back therapy in the long-acting gonadotropin-releasing hormone agonist treatment of uterine leiomyomata.
    Nakayama H; Yano T; Sagara Y; Kikuchi A; Ando K; Wang Y; Watanabe M; Matsumi H; Osuga Y; Momoeda M; Taketani Y
    Gynecol Endocrinol; 1999 Dec; 13(6):382-9. PubMed ID: 10685331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential cost savings using GnRH agonists as preoperative therapy for uterine leiomyomas.
    Saltiel E
    Formulary; 1995 Sep; 30(9):532-4, 542. PubMed ID: 10161243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Size reduction of uterine myomas with monthly administered leuprolide acetate].
    Cheviakoff S; Bocaz JA; Martínez L; Romero C
    Rev Chil Obstet Ginecol; 1994; 59(6):416-20; discussion 420-1. PubMed ID: 7569160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal hemorrhage associated with degenerating submucous leiomyomata during leuprolide acetate treatment.
    Friedman AJ
    Fertil Steril; 1989 Jul; 52(1):152-4. PubMed ID: 2501108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of treatment with gonadotropin releasing hormone agonist on the uterine leiomyomata structure.
    Bozzini N; Rodrigues CJ; Petti DA; Bevilacqua RG; Gonçalves SP; Pinotti JA
    Acta Obstet Gynecol Scand; 2003 Apr; 82(4):330-4. PubMed ID: 12716317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.